← Leaderboards
Richard P Hsung
University Of Minnesota Twin Cities
$4,737,493
Attributed
$4,737,493
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $603.2K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,737,493 · 2
By mechanism
R01$4,737,493 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Ping-Yee Law$10,530,069
- Peter W Carr$3,586,237
- Thomas R Hoye$10,785,872
- Amy Patrice Skubitz$4,565,523
- Gerald J August$14,846,851
Others in their field
Top investigators on “Cyclization”
- Howard Feldman · University Of California, San Diego$16,153,676
- Craig A Townsend · Johns Hopkins University$10,090,731
- Christopher T Walsh · Dana-Farber Cancer Institute$9,301,604
- Larry E. Overman · University Of California Irvine$8,779,872
- David W Christianson · University Of Pennsylvania$8,006,664
- Stephen L Buchwald · Massachusetts Institute Of Technology$7,720,508
Research focus
CyclizationDrug Design /Synthesis /ProductionCycloadditionBiological FactorsMethodologyCholinesterase InhibitorsOrganic SynthesisChemical AdditionChemical Structure FunctionChemical ModelsBiological ProductsBinding SitesAlzheimer'S DiseaseNeuropharmacologic AgentAcetylcholinesterasePyransNitrogenAcidsAlkynesInterestAlkaloidsPropadieneComplexReaction
Grant awards (19)
Allenamides and Ynamides in Organic Synthesis.$291,700
R01 · FY2013 · GM · contact PI
Allenamides and Ynamides in Organic Synthesis.$302,279
R01 · FY2012 · GM · contact PI
Allenamides and Ynamides in Organic Synthesis.$302,279
R01 · FY2011 · GM · contact PI
Allenamides and Ynamides in Organic Synthesis.$305,332
R01 · FY2010 · GM · contact PI
Synthetic Applications of Formal [3+3] Cycloadditions$310,110
R01 · FY2008 · NS · contact PI
Applications of Yn- and Allenamide Cycloadditions$229,820
R01 · FY2008 · GM · contact PI
Synthetic Applications of Formal [3+3] Cycloadditions$310,337
R01 · FY2007 · NS · contact PI
Applications of Yn- and Allenamide Cycloadditions$245,232
R01 · FY2007 · GM · contact PI
Synthetic Applications of Formal [3+3] Cycloadditions$319,833
R01 · FY2006 · NS · contact PI
Applications of Yn- and Allenamide Cycloadditions$236,684
R01 · FY2006 · GM · contact PI
Applications of Yn- and Allenamide Cycloadditions$46,718
R01 · FY2006 · GM · contact PI
Synthetic Applications of Formal [3+3] Cycloadditions$280,540
R01 · FY2005 · NS
Applications of Yn- and Allenamide Cycloadditions$240,609
R01 · FY2005 · GM
Synthetic Applications of Formal [3+3] Cycloadditions$45,300
R01 · FY2005 · NS
Synthetic Applications of Formal [3+3] Cycloadditions$328,675
R01 · FY2004 · NS
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE$214,184
R01 · FY2003 · NS
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE$214,797
R01 · FY2002 · NS
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE$214,378
R01 · FY2001 · NS
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE$298,686
R01 · FY2000 · NS